Better Survival in Morbidly Obese Patients with Atrial Fibrillation Treated with Non-vitamin K-dependent Oral Anticoagulants

BACKGROUND: The efficacy and safety of non-vitamin K-dependent anticoagulants (NOAC) are not well investigated in the obese population, and fixed dosing could lead to under-anticoagulation. Our objective was to evaluate the effect of obesity on anticoagulation outcomes and survival in non-valvular a...

Descripción completa

Detalles Bibliográficos
Autores principales: Albabtain, Monirah A., Alanazi, Zaid, Al Mutairi, Nawaf, Al Hebaishi, Yahya, Alyafi, Ola, Alghasoon, Haneen, Arafat, Amr A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Saudi Heart Association 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069674/
https://www.ncbi.nlm.nih.gov/pubmed/37020973
http://dx.doi.org/10.37616/2212-5043.1327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069674/
https://www.ncbi.nlm.nih.gov/pubmed/37020973
http://dx.doi.org/10.37616/2212-5043.1327

Ejemplares similares